Skip to content

Three-dimensional (3D) Holographic Display for Ultrasound-Guided Structural Heart Disease Procedures

Three-dimensional (3D) Holographic Display for Ultrasound-Guided Structural Heart Disease Procedures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05514626
Enrollment
50
Registered
2022-08-24
Start date
2022-03-24
Completion date
2023-06-30
Last updated
2022-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Structural Cardiac Defects

Brief summary

This study is intended to evaluate the use of the holographic display of 3D images acquired during ultrasound based cardiac procedures and to assess the clinical use of the HOLOSCOPE-i, in providing 3D spatial understanding to the clinician performing the procedure. Patients scheduled to undergo an elective procedure in the Cardiac Catheterization Laboratory which use 3D echocardiography (ECHO) as part of the procedure will be enrolled to this study. In addition to the standard of practice imaging using ultrasound, patients anatomical structures will be evaluated using a 3D holographic system. The patients will complete their participation in the study, at the end of the procedure. No follow-up is required and patients will continue their routine medical care following the procedure.

Interventions

DEVICE3D Holographic Display

3D holographic visualization of the anatomy during the planned interventional procedure. The HOLOSCOPE-i will be used in addition to and will not replace conventional displays that are currently being used during the procedure.

Sponsors

RealView Imaging
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum

Inclusion criteria

* Patients over the age of 18 * Patients are scheduled to undergo an elective procedure in the Cardiac Catheterization Laboratory which use 3D echocardiography (ECHO) as part of the procedure.

Exclusion criteria

* Denial of informed consent * Any contraindications to three-dimensional echocardiographic imaging.

Design outcomes

Primary

MeasureTime frameDescription
HOLOSCOPE-i is of clinical use for ultrasound based cardiac proceduresDuring procedureQualitative assessment using a Likert scale

Secondary

MeasureTime frameDescription
HOLOSCOPE-i provides an intuitive understanding of the spatial relationship of the anatomyDuring procedureQualitative assessment using a Likert scale
HOLOSCOPE-i provides an intuitive understanding of the spatial relationship between the tool and the anatomyDuring procedureQualitative assessment using a Likert scale
Satisfaction with the use of the HOLOSCOPE-i under intra-procedural conditionsDuring procedureQualitative assessment using a Likert scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026